Clene Inc. (CLNN) Insider Trading Disclosures
Clene Inc. (CLNN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLNN
CIK: 1822791
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerKenneth Scriber
Audit LocationSalt Lake City, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-13 | — | SCHEDULE 13G/A Filing | 0000919574-26-006873 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001437749-26-030730 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001437749-26-030729 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | FORM 4 | 0001437749-26-030728 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-15 | FORM 8-K | 0001437749-26-030581 | View SEC Doc Filr Page |
| 424B5 | 2026-09-16 | — | FORM 424B5 | 0001437749-26-030521 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001213900-26-089980 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027973 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027971 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027970 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027968 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027967 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027966 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027965 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001437749-26-027964 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-14 | FORM 8-K | 0001437749-26-027837 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | FORM 10-Q | 0001437749-26-027828 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-11 | — | SCHEDULE 13G/A Filing | 0001835544-26-000023 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | FORM 8-K | 0001437749-26-026653 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-07-17 | PRIMARY DOCUMENT | 0001835544-26-000022 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0000919574-26-004749 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020637 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020636 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020635 | View SEC Doc Filr Page |
| S-8 | 2026-06-05 | — | FORM S-8 | 0001437749-26-019742 | View SEC Doc Filr Page |